World High Life (OTCQB: WRHLF) and its wholly owned subsidiary, Love Hemp, have bounded into the new year with a product launch in almost one-thousand Holland & Barrett International retail stores and the company’s vast online presence throughout the United Kingdom (UK) and Ireland.  It’s a relationship that adds plenty of exposure to the London-based CBD company as it prepares to parlay what was an extremely successful 2020 campaign into an even stronger year of sales for Love Hemp in 2021.

Love Hemp has successfully launched 10 products, including multiple sprays and capsules, across 880 Holland & Barrett stores throughout the UK and Ireland, and online at .  The company said that the products it placed with Holland & Barrett “contain a variety of strengths from 600 mg CBD to 3,000 mg CBD to ensure there is something for everyone whether they are a CBD beginner or an experienced consumer.”

Holland & Barrett provides more than 9,000 SKUs to its customers across a wide range of products, including vitamins and supplements, sports nutrition, natural beauty, and food and drink.  And with over 145 years of experience in the industry, Holland & Barrett is one of the world’s leading health and wellness retailers and the largest in Europe, making the company an ideal partner for Love Hemp and its efforts to become a worldwide brand.

In addition to retail shelf space and an expansive online presence, this deal presents Love Hemp with the opportunity to showcase its products alongside some of the world’s most famous vitamin, nutrition, and natural beauty brands, including Centrum, Seven Seas, MaxiNutrition, Dr Organic and Bioglan.  Love Hemp can now market to and capture a wider audience of shoppers as it continues to spearhead the development of the UK’s leading range of trusted CBD products.  All of Love Hemp’s products are certified THC free, third party tested under strict laboratory conditions, and have a guaranteed CBD concentration.

In addition to leading the UK in the development and sales of CBD products, it’s important to Love Hemp to educate the consumer on all things CBD.  To that end, Love Hemp and Holland & Barrett have implemented a consumer education and awareness program in 400 of Holland & Barrett’s stores to build consumer knowledge around the benefits of CBD.

Love Hemp’s Chief Executive Officer, Tony Calamita, said of the opportunity with Holland & Barrett, “This is a significant relationship not only in its scale, but also because Love Hemp and Holland & Barrett have implemented a ground-breaking education and awareness program designed to inform consumers around the benefits of CBD. The opportunity to play such a leadership role in the category is directly aligned with our values. It is important to invest with partners such as Holland & Barrett to increase knowledge and confidence for consumers so that they know they’re buying credible products from credible retailers.”

This latest news ushers in 2021 with plenty of promise of duplicating and expanding upon a solid 2020 that was spent reaching a myriad of milestones.

Love Hemp spent last year producing impressive sales results month after month, it began expanding its operations to meet overwhelming consumer demand by beginning construction on a new, multi-level, 13,500-square-foot facility that will increase production by more than five times its current output across its entire range of CBD products, including oils, cosmetics, and capsules, and it launched two new brands into the market, Love Hemp Immune and Buzz Leaf.

Love Hemp has over 50 products, including oils, sprays, edibles, cosmetics, and vapes, each available in multiple sizes or applications, and the company currently enjoys over 2000 retail listings.  And now, as we move headlong into 2021, consumers should expect to welcome even more new products given Love Hemp prides itself on the development of new brands to meet the growing demands of its customers.

To learn more about World High Life visit:

To learn more about Love Hemp visit:

For direct questions, call their toll-free number in North America: 1-888-616-9745

About World High Life

World High Life Plc is an investment company with a strategic focus to invest in and/or acquire companies operating in the CBD wellness and medicinal cannabis industry.  The Company’s wholly owned subsidiary, Love Hemp Ltd., is one of the UK’s leading CBD and Hemp product suppliers and has over 50 products, including oils, sprays, edibles, cosmetics, and vapes, each available in multiple sizes or applications, and the company currently enjoys over 2000 retail listings in the UK, including leading brands such as Ocado, Holland & Barrett, and WH Smith.

About Stock Market Media Group

Stock Market Media Group is a news & media content development IR firm offering a platform for corporate stories to unfold in the media with press releases, feature news articles, corporate videos, radio-style CEO interviews, and research reports.

This article was written based on publicly available information. Stock Market Media Group may, from time to time, include our own opinions about the companies, their business, markets, and opportunities in our articles. Any opinions we may offer about any of the companies we write about are solely our own and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of the securities we write about are solely your responsibility based on your own due diligence. Our publications are provided only as an informational aid, and as a starting point for doing additional independent research. We encourage you to invest carefully and read the investor information available at the website of the U.S. Securities and Exchange Commission at , where you can also find all of World High Life’s filings and disclosures. We also recommend, as a general rule, that before investing in any securities, you consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks.  We are not a registered broker, dealer, analyst, or advisor. We hold no investment licenses and may not sell, offer to sell, or offer to buy any security. Our publications about World High Life are not a recommendation to buy or sell a security.

Should Stock Market Media Group and its management own shares in the profiled company, they may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the company’s profile. Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment.  Under the Securities Act of 1933, Section 17(b), Stock Market Media Group discloses that it was remunerated one-thousand, two hundred dollars paid for by a third party via bank wire, to produce this content related to World High Life.

Stock Market Media Group and its management do not own any shares in World High Life and never accepts compensation in free-trading shares for its marketing services of the company being profiled, however third parties that have compensated Stock Market Media Group may hold free-trading shares of the company being profiled and could very well be selling, holding or buying shares of the company’s stock at the same time the content is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

If Stock Market Media Group ever accepts compensation in the form of free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the company’s profile, our disclaimer will be updated accordingly to reflect the current position of any free trading shares received as compensation for our services.

For more information: .


Stock Market Media Group

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less